Activation of human polymorphonuclear leukocytes (PMN) plays a key role in chronic and acute inflammatory processes including infectious disease, septic shock, ischemia-reperfusion injury, arthritis, nephritis, and perhaps resistance to cancer. This program's overall goal is to understand the mechanism of PMN activation. We have discovered that certain cell surface proteins physically interact with complement receptor type 3 (CR3), an inflammation-associated integrin. To capitalize on this finding, we will address the following specific aims using PMNs and/or transfectants expressing native or engineered receptors. We will test the hypothesis that certain glycophospholipid-linked membrane proteins, such as urokinase receptors (uPAR), reversibly interact with CR3. Experimental methods sensitive to receptor-receptor proximity and lateral mobility will be used to characterize these interactions, which will be linked with signal transduction and cell migration. We will examine CR4-to uPAR interactions on PMNs and provide experimental tests of the phase-locked signal transduction hypothesis and its cellular origin. The mechanism of uPAR-integrin interactions and their physiological relevance will be examined. To analyze the molecular mechanism of FcRIII-CR3 interaction, allotypic variants of FcRIIIB in PMNs and transfectants expressing FcRIII with selected deletion of N-linked consensus sequences will be studied. We will test the hypothesis that FcRII interacts with CR3 using transfectants that express these native proteins of defective forms (FcRII- or CR3-) that lack their cytoplasmic domains and internalization ability. Using a reverse genetic complementation approach, we will test the ability of wild-type CR3 or FcRII to rescue internalization mediated by ligation of FcRII- or CR3-, respectively. Physical association will be studied using biophysical and immunoprecipitation techniques whereas functional associations will be monitored using transmembrane signaling and phagocytosis assays. Our studies will determine the nature and mechanisms of inter-receptor interactions, which may lead to the development of new anti-inflammatory agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027409-09
Application #
2837402
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Kraemer, Kristy A
Project Start
1988-12-01
Project End
2001-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Wayne State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Petty, Howard R (2004) Detection of cytokine signal transduction ""cross-talk"" in leukocyte activation. Methods Mol Biol 249:219-28
Olsen, Lars F; Kummer, Ursula; Kindzelskii, Andrei L et al. (2003) A model of the oscillatory metabolism of activated neutrophils. Biophys J 84:69-81
Albrecht, Eric; Kindzelskii, Andrei L; Petty, Howard R (2003) Signal processing times in neutrophil activation: dependence on ligand concentration and the relative phase of metabolic oscillations. Biophys Chem 106:211-9
Elner, Susan G; Elner, Victor M; Kindzelskii, Andrei L et al. (2003) Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase. Exp Eye Res 76:585-95
Petty, Howard R; Worth, Randall G; Todd 3rd, Robert F (2002) Interactions of integrins with their partner proteins in leukocyte membranes. Immunol Res 25:75-95
Xia, Yu; Borland, Gita; Huang, Jibiao et al. (2002) Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J Immunol 169:6417-26
Worth, R G; Esper, R M; Warra, N S et al. (2001) Mercury inhibition of neutrophil activity: evidence of aberrant cellular signalling and incoherent cellular metabolism. Scand J Immunol 53:49-55
Worth, R G; Mayo-Bond, L; Kim, M K et al. (2001) The cytoplasmic domain of FcgammaRIIA (CD32) participates in phagolysosome formation. Blood 98:3429-34
Sitrin, R G; Pan, P M; Blackwood, R A et al. (2001) Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils. J Immunol 166:4822-5
Horino, K; Kindezelskii, A L; Elner, V M et al. (2001) Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation. FASEB J 15:932-9

Showing the most recent 10 out of 51 publications